How Does Emergent Biosolutions Inc (EBS) Stock Rank on Wall Street Thursday?

InvestorsObserver is giving Emergent Biosolutions Inc (EBS) an Analyst Rating Rank of 5, meaning EBS is ranked higher by analysts than 5% of stocks. The average price target for EBS is $5 and analyst’s rate the stock as a Hold.

Wall Street analysts are rating EBS a Hold today. Find out what this means to you and get the rest of the rankings on EBS!

See Full EBS Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Emergent Biosolutions Inc Stock Today?

Emergent Biosolutions Inc (EBS) stock has risen 1.79% while the S&P 500 has fallen -0.33% as of 12:52 PM on Thursday, Mar 14. EBS has gained $0.04 from the previous closing price of $2.24 on volume of 933,881 shares. Over the past year the S&P 500 is up 32.29% while EBS has fallen -76.37%. EBS lost -$14.85 per share the over the last 12 months. Click Here to get the full Stock Report for Emergent Biosolutions Inc stock.